TFF PHARMACEUTICALS INC's ticker is TFFP and the CUSIP is 87241J104. A total of 46 filers reported holding TFF PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -20.0% | 22,066 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $10 | -33.3% | 22,066 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $15 | -34.8% | 22,066 | 0.0% | 0.01% | -33.3% |
| Q4 2022 | $23 | -100.0% | 22,066 | 0.0% | 0.01% | -73.5% |
| Q3 2022 | $90,000 | -28.0% | 22,066 | 0.0% | 0.03% | -37.0% |
| Q2 2022 | $125,000 | -10.1% | 22,066 | 0.0% | 0.05% | -25.0% |
| Q1 2022 | $139,000 | -29.1% | 22,066 | 0.0% | 0.07% | -19.1% |
| Q4 2021 | $196,000 | +15.3% | 22,066 | 0.0% | 0.09% | -8.2% |
| Q3 2021 | $170,000 | -19.8% | 22,066 | 0.0% | 0.10% | -40.5% |
| Q2 2021 | $212,000 | -29.1% | 22,066 | 0.0% | 0.16% | -6.9% |
| Q1 2021 | $299,000 | -90.5% | 22,066 | -90.0% | 0.18% | -94.9% |
| Q4 2020 | $3,160,000 | -22.5% | 220,666 | 0.0% | 3.42% | -19.3% |
| Q3 2020 | $4,076,000 | – | 220,666 | – | 4.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,350,000 | $19,332,000 | 4.60% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 220,666 | $3,160,000 | 3.42% |
| Mesirow Financial Investment Management, Inc. | 27,963 | $400,430,000 | 1.27% |
| Gagnon Advisors, LLC | 176,471 | $2,527,000 | 1.14% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,148,000 | 0.87% |
| Nantahala Capital Management | 1,763,476 | $25,253,000 | 0.78% |
| GAGNON SECURITIES LLC | 232,865 | $3,335,000 | 0.53% |
| Sepio Capital, LP | 92,084 | $1,319,000 | 0.11% |
| 683 Capital Management, LLC | 142,024 | $2,034,000 | 0.10% |
| SANDERS MORRIS HARRIS LLC | 21,326 | $394,000 | 0.09% |